CFML
ATNM icon

COMPASS FINANCIAL MANAGEMENT LLC’s Actinium Pharmaceuticals ATNM Stock Holding History

COMPASS FINANCIAL MANAGEMENT LLC’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$588K Buy
+600,230
New +$693K 0.07% 251

Other funds holding ATNM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GWP
Gen-Wealth Partners Zeeland, Michigan $360M AUM 27.44% 1-Year Est. Return
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
SFG
SNS Financial Group Minneapolis, Minnesota $5.2B AUM 22.05% 1-Year Est. Return
AIS
AM Investment Strategies Chattanooga, Tennessee $521M AUM 33.22% 1-Year Est. Return
GBFG
Gerald Baker Financial Group Arlington, Texas $351M AUM
ML
Mayport LLC Newton, Massachusetts $645M AUM 19.45% 1-Year Est. Return

COMPASS FINANCIAL MANAGEMENT LLC's ATNM Position: Q2 2026 in Review

COMPASS FINANCIAL MANAGEMENT LLC opened a new position in Actinium Pharmaceuticals (ATNM) in Q2 2026: 600,230 shares worth $588K. The stake represents 0.07% of the portfolio and ranks #251 among its holdings.

25 funds tracked by Wall St. Rank hold ATNM as of Q2 2026.

  • COMPASS FINANCIAL MANAGEMENT LLC held 600,230 shares of Actinium Pharmaceuticals worth $588K as of Q2 2026.
  • Actinium Pharmaceuticals was a new COMPASS FINANCIAL MANAGEMENT LLC position in Q2 2026.
  • Actinium Pharmaceuticals made up 0.07% of COMPASS FINANCIAL MANAGEMENT LLC's portfolio in Q2 2026, its #251 holding.
  • 25 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2026.

Based on COMPASS FINANCIAL MANAGEMENT LLC's 13F filing for Q2 2026, filed 12 Aug 2026.